Chemotherapy for Breast Cancer

Chemotherapy (chemo) uses anti-cancer drugs that may be given intravenously (injected into your vein) or by mouth. The drugs travel through the bloodstream to reach cancer cells in most parts of the body. Occasionally, chemo may be given directly into the spinal fluid which surrounds the brain and spinal cord.  

When is chemotherapy used?

Not all women with breast cancer will need chemo, but there are several situations in which chemo may be recommended:

  • After surgery (adjuvant chemotherapy): Adjuvant chemo might be given to try to kill any cancer cells that might have been left behind or have spread but can't be seen, even on imaging tests. If these cells were allowed to grow, they could form new tumors in other places in the body. Adjuvant chemo can lower the risk of breast cancer coming back.
  • Before surgery (neoadjuvant chemotherapy): Neoadjuvant chemo might be given to try to shrink the tumor so it can be removed with less extensive surgery. Because of this, neoadjuvant chemo is often used to treat cancers that are too big to be removed by surgery when first diagnosed (called locally advanced cancers). Also, by giving chemo before the tumor is removed, doctors can see how the cancer responds to it. If the first set of chemo drugs doesn’t shrink the tumor, your doctor will know that other drugs are needed. It should also kill any cancer cells that have spread but can't be seen. Just like adjuvant chemo, neoadjuvant chemo can lower the risk of breast cancer coming back.  

For certain types of breast cancer, if there are tumor cells still found at the time of surgery (also called residual disease), you may be offered more chemotherapy after surgery to reduce the chances of the cancer coming back (recurrence).

  • For advanced breast cancer: Chemo can be used as the main treatment for women whose cancer has spread outside the breast and underarm area, either when it is diagnosed or after initial treatments. The length of treatment depends on how well the chemo is working and how well you tolerate it.

Sometimes it is not clear if chemotherapy will be helpful. There are tests available, such as Oncotype DX, that can help determine which women will most likely benefit from chemo after breast surgery. See Breast Cancer Gene Expression Tests for more information. 

Chemotherapy drugs used for breast cancer

Chemotherapy can be given before surgery (neoadjuvant) or after surgery (adjuvant). In most cases, chemo is most effective when combinations of drugs are used. Today, doctors use many different combinations, and it's not clear that any single combination is clearly the best.

Adjuvant and neoadjuvant drugs

  • Anthracyclines, such as doxorubicin (Adriamycin) and epirubicin (Ellence)
  • Taxanes, such as paclitaxel (Taxol) and docetaxel (Taxotere)
  • 5-fluorouracil (5-FU) or capecitabine
  • Cyclophosphamide (Cytoxan)
  • Carboplatin (Paraplatin)

Most often, combinations of 2 or 3 of these drugs are used.

Drugs for breast cancer that has spread (advanced breast cancer)

  • Taxanes, such as paclitaxel (Taxol), docetaxel (Taxotere), and albumin-bound paclitaxel (Abraxane)
  • Anthracyclines (Doxorubicin, pegylated liposomal doxorubicin, and Epirubicin﻿)
  • Platinum agents (cisplatin, carboplatin)
  • Vinorelbine (Navelbine)
  • Capecitabine (Xeloda)
  • Gemcitabine (Gemzar)
  • Ixabepilone (Ixempra)
  • Eribulin (Halaven)


For cancers that are HER2-positive, one or more drugs that target HER2 may be used with chemo. (See Targeted Therapy for Breast Cancer for more information about these drugs.)

How is chemotherapy given?

Chemo drugs for breast cancer are typically given into a vein (IV), either as an injection over a few minutes or as an infusion over a longer period of time. This can be done in a doctor’s office, infusion center, or in a hospital setting.

Often, a slightly larger and sturdier IV is required in the vein system to administer chemo. These are known as central venous catheters (CVCs), central venous access devices (CVADs), or central lines. They are used to put medicines, blood products, nutrients, or fluids right into your blood. They can also be used to take out blood for testing.

There are many different kinds of CVCs. The most common types are the port and the PICC line. For breast cancer patients, the central line is typically placed on the side opposite of the underarm that had lymph nodes removed for the breast cancer surgery.

Chemo is given in cycles, followed by a rest period to give you time to recover from the effects of the drugs. Cycles are most often 2 or 3 weeks long. The schedule varies depending on the drugs used. For example, with some drugs, the chemo is given only on the first day of the cycle. With others, it is given for a few days in a row, or once a week. Then, at the end of the cycle, the chemo schedule repeats to start the next cycle.

Adjuvant and neoadjuvant chemo is often given for a total of 3 to 6 months, depending on the drugs used. The length of treatment for advanced breast cancer depends on how well it is working and what side effects you have.

Dose-dense chemotherapy

Doctors have found that giving the cycles of certain chemo drugs closer together can lower the chance that the cancer will come back and improve survival for some women. For example, a drug that would normally be given every 3 weeks might be given every 2 weeks. This can be done for both neoadjuvant and adjuvant treatment. It can lead to more problems with low blood cell counts, so it’s not an option for all women.  A chemo combination sometimes given this way is doxorubicin (Adriamycin) and cyclophosphamide (Cytoxan), followed by weekly paclitaxel (Taxol).

Possible side effects of chemo for breast cancer

Chemo drugs can cause side effects. These depend on the type and dose of drugs given, and the length of treatment. Some of the most common possible side effects include:

  • Hair loss
  • Nail changes
  • Mouth sores
  • Loss of appetite or weight changes
  • Nausea and vomiting
  • Diarrhea

Chemo can also affect the blood-forming cells of the bone marrow, which can lead to:

  • Easy bruising or bleeding (from low blood platelet counts)
  • Fatigue (from low red blood cell counts and other reasons)


Other side effects are also possible. Some of these are more common with certain chemo drugs. Ask your cancer care team about the possible side effects of the specific drugs you are getting.

Menstrual changes and fertility issues

For younger women, changes in menstrual periods are a common side effect of chemo. Premature menopause (not having any more menstrual periods) and infertility (not being able to become pregnant) may occur and may be permanent. Some chemo drugs are more likely to cause this than others. The older a woman is when she gets chemotherapy, the more likely it is that she will go through menopause or become infertile as a result. When this happens, there is an increased risk of bone loss and osteoporosis. There are medicines that can treat or help prevent bone loss.

Even if your periods have stopped while you are on chemo, you may still be able to get pregnant. Getting pregnant while on chemo could lead to birth defects and interfere with treatment. If you are pre-menopausal before treatment and are sexually active, it’s important to discuss using birth control with your doctor. It is not a good idea for women with hormone receptor-positive breast cancer to take hormonal birth control (like birth control pills), so it’s important to talk with both your oncologist and your gynecologist (or family doctor) about what options would be best in your case. Women who have finished treatment (like chemo) can safely go on to have children, but it's not safe to get pregnant while on treatment.

If you think you might want to have children after being treated for breast cancer, talk with your doctor before you start treatment. Learn more from our section on fertility concerns for women with cancer.

If you are pregnant when you get breast cancer, you still can be treated. Certain chemo drugs can be taken safely during the last 2 trimesters of pregnancy. We have more details in our section on breast cancer during pregnancy.

Heart damage

Even though it is not common, doxorubicin, epirubicin, and some other chemo drugs can cause permanent heart damage (called cardiomyopathy). The risk is highest if the drug is used for a long time or in high doses. Damage from these drugs also happens more often if other drugs that can cause heart damage (such as those that target HER2) are used.  Other heart failure risk factors, such as family history of heart problems, high blood pressure, and diabetes can also put you at risk if you receive one of these drugs.

Most doctors will check your heart function with a test like an echocardiogram (an ultrasound of the heart) or a MUGA scan before starting one of these drugs. They also carefully control the doses, watch for symptoms of heart problems, and may regularly repeat heart tests during treatment. If the heart function begins to worsen, treatment with these drugs will be temporarily or permanently stopped. Still, in some people, signs of damage might not appear until months or years after treatment stops.

Nerve damage (neuropathy)

Many drugs used to treat breast cancer, including taxanes (docetaxel, paclitaxel, and protein-bound paclitaxel), platinum agents (carboplatin, cisplatin), vinorelbine, eribulin, and ixabepilone, can damage nerves in the hands and arms and feet and legs. This can sometimes lead to symptoms in those areas like numbness, pain, burning or tingling sensations, sensitivity to cold or heat, or weakness. In most cases these symptoms go away once treatment is stopped, but in some women it might last a long time or may become permanent. There are medicines that could help with these symptoms .

Hand-foot syndrome

Certain chemo drugs, such as capecitabine and liposomal doxorubicin, can irritate the palms of the hands and the soles of the feet. This is called hand-foot syndrome. Early symptoms include numbness, tingling, and redness. If it gets worse, the hands and feet can become swollen and uncomfortable or even painful. The skin may blister, leading to peeling or even open sores. There is no specific treatment, although some creams or steroids given before chemo may help. These symptoms gradually get better when the drug is stopped or the dose is lowered. The best way to prevent severe hand-foot syndrome is to tell your doctor when symptoms first come up, so that the drug dose can be changed or other medicines can be given.

Chemo brain

Many women who are treated with chemotherapy for breast cancer report a slight decrease in mental functioning. They may have some problems with concentration and memory, which may last a long time. Although many women have linked this to chemo, it also has been seen in women who did not get chemo as part of their treatment. Still, most women function well after treatment. In studies that have found chemo brain to be a side effect of treatment, the symptoms most often last for a few years.

Increased risk of leukemia

Very rarely, certain chemo drugs can cause diseases of the bone marrow, such as myelodysplastic syndromes or even acute myeloid leukemia, a cancer of white blood cells. If this happens, it is usually within 10 years after treatment. For most women, the benefits of chemo in helping prevent breast cancer from coming back or in extending life are far likely to exceed the risk of this rare but serious complication﻿.

Feeling unwell or tired (fatigue)



More information about chemotherapy



The American Cancer Society medical and editorial content team


Almuwaqqat Z, Meisel JL, Barac A, Parashar S. Breast Cancer and Heart Failure. Heart Fail Clin. 2019 Jan;15(1):65-75.

Callahan RD and Ganz PA. Chapter 52: Long-Term and Late Effects of Primary Curative Intent Therapy: Neurocognitive, Cardiac, and Secondary Malignancies.   In:  Harris JR, Lippman ME, Morrow M, Osborne CK, eds. Diseases of the Breast. 5th ed. Philadelphia: Wolters Kluwer Health; 2014.

Dang C and Hudis CA. Chapter 44: Adjuvant Systemic Chemotherapy in Early Breast Cancer. In:  Harris JR, Lippman ME, Morrow M, Osborne CK, eds. Diseases of the Breast. 5th ed. Philadelphia: Wolters Kluwer Health; 2014.

Hermelink K. Chemotherapy and Cognitive Function in Breast Cancer Patients: The So-Called Chemo Brain. J Natl Cancer Inst Monogr. 2015 May;2015(51):67-9.

Henry NL, Shah PD, Haider I, Freer PE, Jagsi R, Sabel MS. Chapter 88: Cancer of the Breast. In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE, eds. Abeloff’s Clinical Oncology. 6th ed. Philadelphia, Pa: Elsevier; 2020.

Jagsi R, King TA, Lehman C, Morrow M, Harris JR, Burstein HJ. Chapter 79: Malignant Tumors of the Breast. In: DeVita VT, Lawrence TS, Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology. 11th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2019.

National Cancer Institute. Physician Data Query (PDQ). Breast Cancer Treatment – Health Professional Version. 2019. Accessed at on July 19, 2019.

National Comprehensive Cancer Network (NCCN). Practice Guidelines in Oncology: Breast Cancer. Version 2.2019. Accessed at on July 18, 2019.

Osborne CK. Chapter 53: Adjuvant Systemic Therapy Treatment Guidelines. In:  Harris JR, Lippman ME, Morrow M, Osborne CK, eds. Diseases of the Breast. 5th ed. Philadelphia: Wolters Kluwer Health; 2014.

Last Medical Review: September 18, 2019 Last Revised: September 18, 2019
